Q:
A:
Work on national medicines policy to accelerate
Belgrade,
22 September 2005
Representatives of the Serbian Ministry of Health and the pharmaceutical sector held a meeting today concerning the national medicines policy, after which they announced that they will accelerate the work on this document, which should provide greater quality, availability and rational distribution of medicines.
Author:
Beta
Minister of Health Tomica Milosavljevic said that for a long period of time, the medication market has been relatively stable and well supplied. The pharmaceutical sector will undergo a harmonisation process with EU standards, and one of the more urgent tasks is creating an essential medicines list, which is a basic element of a successful medicines policy.
According to the World Health Organisation (WHO), the essential medicines list comprises the medicines that must be in stock at any moment and in any part of the country, he explained.
Head of WHO’s Belgrade office Luigi Migliorini said that WHO’s recommendations on the essential medicines list provide a base for any country to which they can add medicines depending on their specific health needs.
According to WHO coordinator Melita Vujnovic, the role of the essential medicines list in Serbia is to direct the Ministry of Health and the Health Insurance Fund while defining a positive list and enabling an increased availability of medicines.
She said that WHO is currently using the list adopted in 2003, which contains 316 active substances divided into 27 therapeutic groups, and adoption of a new list for 2005 is expected.
Today’s meeting was organised by the Ministry of Health, the WHO office for Serbia-Montenegro and the European Agency for Reconstruction.
According to the World Health Organisation (WHO), the essential medicines list comprises the medicines that must be in stock at any moment and in any part of the country, he explained.
Head of WHO’s Belgrade office Luigi Migliorini said that WHO’s recommendations on the essential medicines list provide a base for any country to which they can add medicines depending on their specific health needs.
According to WHO coordinator Melita Vujnovic, the role of the essential medicines list in Serbia is to direct the Ministry of Health and the Health Insurance Fund while defining a positive list and enabling an increased availability of medicines.
She said that WHO is currently using the list adopted in 2003, which contains 316 active substances divided into 27 therapeutic groups, and adoption of a new list for 2005 is expected.
Today’s meeting was organised by the Ministry of Health, the WHO office for Serbia-Montenegro and the European Agency for Reconstruction.
-
Belgrade, 28 November 2025Serbia, Italy dedicated to further strengthening partnership
-
Belgrade, 28 November 2025Partnership with EU important for improvement of human, minority rights
-
Belgrade, 28 November 2025Italy one of Serbia’s most important bilateral partners
-
Belgrade, 28 November 2025Four bilateral documents exchanged between Serbia, DR Congo
-
Belgrade/The Hague, 27 November 2025Serbia committed to European integration process
-
Belgrade, 27 November 2025Strengthening relations between Serbia, France through major infrastructure projects
-
Belgrade, 27 November 2025Serbia, Germany dedicated to intensifying cooperation in field of agriculture
-
Belgrade, 27 November 2025Cooperation with Montenegro in modernising public administration
-
Belgrade, 26 November 2025CEI region remains committed to connectivity, integration, innovation
-
Belgrade, 26 November 2025Joint work of Serbia, Ukraine in European integration process